SuperworthAkari Therapeutics Plc shares outstanding AKTX
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 143.3B
- On a year earlier
- +9007.6%
- more shares
Akari Therapeutics Plc had 143.3B diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 9007.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 2.2B | +123% |
| FY2024 | 967.7M | +339% |
| FY2023 | 220.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 143.3B | +9008% | |
| Q1 FY26 | 118.8B | +8602% | |
| Q4 FY25 | 2.2B | +123% | |
| Q3 FY25 | 1.6B | +168% | |
| Q2 FY25 | 1.6B | +234% | |
| Q1 FY25 | 1.4B | +306% | |
| Q4 FY24 | 967.7M | +339% | |
| Q3 FY24 | 609.7M | +141% | |
| Q2 FY24 | 470.9M | +86% | |
| Q1 FY24 | 336.3M | +78% | |
| Q4 FY23 | 220.2M | n/a | |
| Q3 FY23 | 252.9M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Akari Therapeutics Plc
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.